BR9911217A - Métodos para ampliação dos nìveis de acetilcolina - Google Patents

Métodos para ampliação dos nìveis de acetilcolina

Info

Publication number
BR9911217A
BR9911217A BR9911217-5A BR9911217A BR9911217A BR 9911217 A BR9911217 A BR 9911217A BR 9911217 A BR9911217 A BR 9911217A BR 9911217 A BR9911217 A BR 9911217A
Authority
BR
Brazil
Prior art keywords
methods
acetylcholine levels
increasing acetylcholine
levels
increasing
Prior art date
Application number
BR9911217-5A
Other languages
English (en)
Inventor
Henry Uhlman Bryant
Michele Annette Glinn
Steven Marc Paul
Xin Wu
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9911217A publication Critical patent/BR9911217A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

Patente de Invenção: <B>"MéTODOS PARA AMPLIAçãO DOS NìVEIS DE ACETILCOLINA"<D>. A presente invenção refere-se a um método para ampliação dos níveis de acetilcolina compreendendo a administração a um mamífero necessitado da mesma de uma quantidade eficiente de um composto de fórmula I e, opcionalmente, de um inibidor de AChE.
BR9911217-5A 1998-06-16 1999-06-04 Métodos para ampliação dos nìveis de acetilcolina BR9911217A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8948898P 1998-06-16 1998-06-16
PCT/US1999/012603 WO1999065309A1 (en) 1998-06-16 1999-06-04 Methods for increasing levels of acetylcholine

Publications (1)

Publication Number Publication Date
BR9911217A true BR9911217A (pt) 2001-03-06

Family

ID=22217922

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9911217-5A BR9911217A (pt) 1998-06-16 1999-06-04 Métodos para ampliação dos nìveis de acetilcolina

Country Status (17)

Country Link
EP (1) EP0966964A1 (pt)
JP (1) JP2002518299A (pt)
KR (1) KR20010052892A (pt)
CN (1) CN1305343A (pt)
AU (1) AU748659B2 (pt)
BR (1) BR9911217A (pt)
CA (1) CA2333453A1 (pt)
HR (1) HRP20000861A2 (pt)
HU (1) HUP0103834A2 (pt)
IL (1) IL138914A0 (pt)
NO (1) NO20006088D0 (pt)
PL (1) PL346242A1 (pt)
SK (1) SK18812000A3 (pt)
TR (1) TR200003714T2 (pt)
TW (1) TW486367B (pt)
WO (1) WO1999065309A1 (pt)
ZA (1) ZA200005885B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1305377A (zh) 1998-06-16 2001-07-25 伊莱利利公司 提高乙酰胆碱水平的方法
US6288108B1 (en) 1998-06-16 2001-09-11 Eli Lilly And Company Methods for increasing levels of acetylcholine
KR101226702B1 (ko) * 2010-10-08 2013-01-25 충북대학교 산학협력단 인간 콜린 아세틸트랜스퍼라아제를 발현하는 인간 신경줄기세포 및 이의 용도
KR102117741B1 (ko) * 2017-12-31 2020-06-01 롯데첨단소재(주) 도금용 열가소성 수지 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0735821A4 (en) * 1993-12-21 1998-04-01 Lilly Co Eli METHODS FOR TREATING OR PREVENTING CONDITIONS ASSOCIATED WITH AMYLO DOGEN PEPTIDES
US5552415A (en) * 1993-12-21 1996-09-03 Eli Lilly And Company Method of inhibiting Alzheimer's Disease
US5510357A (en) * 1995-02-28 1996-04-23 Eli Lilly And Company Benzothiophene compounds as anti-estrogenic agents
ES2163587T3 (es) * 1995-02-28 2002-02-01 Lilly Co Eli Compuestos de benzotiofeno, productos intermedios, composiciones y procedimientos.
AU731282B2 (en) * 1996-06-07 2001-03-29 Eisai Co. Ltd. Polymorphs of donepezil hydrochloride and process for production
ZA982877B (en) * 1997-04-09 1999-10-04 Lilly Co Eli Treatment of central nervous system disorders with selective estrogen receptor modulators.

Also Published As

Publication number Publication date
CN1305343A (zh) 2001-07-25
WO1999065309A1 (en) 1999-12-23
NO20006088L (no) 2000-11-30
SK18812000A3 (sk) 2002-01-07
PL346242A1 (en) 2002-01-28
HRP20000861A2 (en) 2001-10-31
AU4819199A (en) 2000-01-05
IL138914A0 (en) 2001-11-25
AU748659B2 (en) 2002-06-06
JP2002518299A (ja) 2002-06-25
CA2333453A1 (en) 1999-12-23
TW486367B (en) 2002-05-11
HUP0103834A2 (hu) 2002-05-29
TR200003714T2 (tr) 2001-07-23
EP0966964A1 (en) 1999-12-29
ZA200005885B (en) 2001-10-22
KR20010052892A (ko) 2001-06-25
NO20006088D0 (no) 2000-11-30

Similar Documents

Publication Publication Date Title
BR9908275A (pt) Inibidores de enzimas fosfolipase
BR9811099A (pt) Inibidores de urocinase
DK0766672T3 (da) Arylsulfonamido-substituerede hydroxamsyrer som matrixmetallopreteinase-inhibitorer
BR0113961A (pt) Método de analgesia
LU91926I2 (fr) Belimumab et ses dérivés pharmaceutiquement acceptables (Benlysta®)
BRPI0407922A (pt) derivados de isoquinolina e métodos de uso destes
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
NO20003018D0 (no) Triazinangiogenese-inhibitorer
BG103995A (en) Reverse hydroxamate inhibitors of matrix metalloprreverse hydroxamate inhibitors of matrix metallprooteinases teinases
PT1250340E (pt) Metodos e compostos para inibicao de mrp1
BR9907655A (pt) Derivados de ácido di-hidróxi-hexanóico
KR960006915A (ko) 췌장염의 치료 조성물
BR9905089A (pt) Derivados macrolìdeos
WO2005046672A3 (fr) Utilisation d’inhibiteurs de glucosidase pour une therapie de la mucoviscidose
BR0110208A (pt) Composições e terapias para distúrbios associados com hiperlipidemia
BR9810616A (pt) Inibidores de farnesil transferase em combinação com inibidores de hmg coa redutase para o tratamento do cancer
BR9911217A (pt) Métodos para ampliação dos nìveis de acetilcolina
BR9911220A (pt) Métodos para ampliação dos nìveis de acetilcolina
BR9811937A (pt) Método de aumentar a biodisponibilidade de fexofenadina e de seus derivados
BR9809673A (pt) Derivados de triptolida úteis no tratamento de doenças autoimunes
BR0012058A (pt) Combinação sinérgica: gabapentina e pregabalina
BR9911224A (pt) Métodos para redução dos nìveis de homocisteìna e proteìna c-reativa
BR0116554A (pt) Composto, composição farmacêutica para o tratamento da angina ou hipertensão, processo, processo para o tratamento ou prevenção da angina ou hipertensão, composição do ingrediente farmaceuticamente ativo e composição farmacêutica para o tratamento ou prevenção da angina ou hipertensão
BR0007183A (pt) Isonipectoamidas para o tratamento de distúrbios mediados por integrina
BR0212607A (pt) Agonistas retinóides ii de uréia substituìda

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5,6,7 E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007.